Factors Associated With the Location of Expected Pediatric Deaths in the Palliative Care Context

Sandra Coombs1, Phillip Aouad1,2, Tiina Jaaniste1,2,3

  • 1Departments of Pain and Palliative Care, Sydney Children's Hospital - Randwick, Sydney, Australia.

Omega
|September 17, 2020
PubMed

Insights

Early planning for a child

Area of Science:

  • Palliative care and pediatric end-of-life planning.

Background:

  • Hasty decisions regarding the location of death (LOD) for palliative children can burden families.
  • Early planning empowers families and provides a sense of control during end-of-life care.

Purpose of the Study:

  • To review factors associated with pediatric location of death (LOD) planning.
  • To identify emerging factors crucial for integrative pediatric end-of-life planning.

Main Methods:

  • Literature review of factors influencing pediatric location of death (LOD) decisions.
  • Identification and categorization of health service, familial, and patient factors.
  • Development of a conceptual model for pediatric LOD planning.

Main Results:

  • Three key areas identified: health service factors, familial factors, and patient factors.
  • Multiple sub-factors within these areas were presented.
  • A conceptual model illustrating related factors in pediatric LOD planning was developed.

Conclusions:

  • Comprehensive planning for pediatric location of death (LOD) is essential.
  • Further research is needed to address the limited empirical data in this field.
  • Understanding nuanced implications of LOD factors requires continued investigation.

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
166
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
145
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
1.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
559